Ontology highlight
ABSTRACT: Objective
Assessment of the safety and efficacy of a 10-day melarsoprol schedule in second stage T.b. rhodesiense patients and the effect of suramin-pretreatment on the incidence of encephalopathic syndrome (ES) during melarsoprol therapy.Design
Sequential conduct of a proof-of-concept trial (n = 60) and a utilization study (n = 78) using historic controls as comparator.Setting
Two trial centres in the T.b. rhodesiense endemic regions of Tanzania and Uganda.Participants
Consenting patients with confirmed second stage disease and a minimum age of 6 years were eligible for participation. Unconscious and pregnant patients were excluded.Main outcome measures
The primary outcome measures were safety and efficacy at end of treatment. The secondary outcome
SUBMITTER: Kuepfer I
PROVIDER: S-EPMC3435133 | biostudies-literature | 2012 Aug
REPOSITORIES: biostudies-literature